Avanos Medical Inc

Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm’s portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Avanos Medical Inc reports robust Q4 results and outlines growth strategies

Avanos Medical Inc delivered strong financial performance in Q4 2022, showcasing growth in key product categories and exceeding expectations in OrthogenRx. While facing challenges in certain segments, Avanos is focused on optimizing operations and capitalizing on identified opportunities for growth.

Avanos Medical reports steady Q1 performance amidst strategic transformation

Avanos Medical Inc's Q1 2023 performance was steady, with a focus on operational efficiency and profitability enhancement.
While facing challenges in certain product categories, Avanos is well-positioned to capitalize on growth opportunities through strategic initiatives.
The company's transformation priorities and guidance for the year reflect a proactive approach to navigating market dynamics and driving sustainable value creation.

Avanos Medical Inc reports resilient Q2 performance and outlines growth strategies

Avanos Medical Inc demonstrated resilience in Q2 amidst supply chain challenges and inflation effects.
The company's focus on strategic priorities and shareholder value enhancement initiatives bode well for future growth.
Despite some portfolio challenges, Avanos remains optimistic about mid-single-digit revenue growth in 2024.
Operational efficiency and growth opportunities in key product lines position Avanos for sustained success.

Avanos Medical Inc reports Q3 results, focuses on efficiency and growth

Avanos Medical Inc's Q3 performance reflects mixed results with growth in Digestive Health but decline in Pain Management portfolios.
The company's transformation priorities and cost management efforts aim to drive efficiency and optimize performance.
Despite challenges in certain product segments, Avanos Medical Inc's focus on gross margin improvement and savings targets bode well for future profitability.
Opportunities lie in portfolio transformation, enhanced gross margins, and strategic initiatives like DIros Technology and cost optimization.

Avanos Medical Inc reports stable Q4 earnings amidst growth strategies

Avanos Medical Inc's Q4 performance reflects mixed results with challenges in certain product segments but stable profitability.
The company's strategic priorities aim to drive future growth through portfolio optimization and cost management.
Anticipated revenue growth, focus on M&A, and long-term financial targets position Avanos for sustainable performance and expansion.

Avanos Medical Inc reports solid Q1 performance and growth outlook

Avanos Medical Inc's Q1 2024 performance showed mixed results across portfolios but strong overall financials.
The company's focus on cost management, capital efficiency, and strategic targets bodes well for future growth.
Despite challenges in certain product lines, Avanos remains confident in its strategies and growth trajectory.

Avanos Medical reports resilient Q2 results amidst portfolio growth

Avanos Medical's Q2 performance showcased solid sales figures and growth in key portfolios, despite challenges in certain segments.
The company's strengths lie in maintaining financial guidance, a strong balance sheet, and a strategic focus on transformation initiatives.
While facing challenges in specific product lines, Avanos Medical has opportunities to drive growth through product innovation, strategic partnerships, and capital allocation.
Overall, Avanos Medical remains committed to its transformation journey and delivering value to shareholders through prudent financial management.

Avanos Medical reports Q3 results, focuses on growth strategies

Avanos Medical's Q3 performance reflects a mixed picture with strong Digestive Health growth but challenges in the pain portfolio.
The company's strategic focus on high-margin products, cost management, and growth initiatives positions it for future success.
Despite current challenges, Avanos Medical's pursuit of organic growth, efficient capital allocation, and strategic M&A bode well for long-term value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer

ALPHARETTA, Ga., Sept. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in September

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Why Is Avanos Medical (AVNS) Up 5.7% Since Last Earnings Report?

ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain

ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General Manager, Pain Franchise

Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2020 Results - Earnings Call Transcript

Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Q2 Earnings and Revenues Surpass Estimates

ALPHARETTA, Ga., Aug. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Avanos Medical, Inc. Announces Second Quarter 2020 Results

Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avanos Medical (AVNS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

ALPHARETTA, Ga., May 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June: Conference: Jefferies Virtual Healthcare Conference Presentation Date: Thurs. June 4 at approximately 1:30 p.m....

Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in June

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Here's Why You Should Hold on to Avanos Medical Stock Now

Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?

Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.

Here's Why You Should Hold Avanos Medical (AVNS) Stock Now

Avanos (AVNS) gains from segmental contributions in Q4.

Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript

Why Is Avanos Medical (AVNS) Down 1.8% Since Last Earnings Report?

Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.

Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2019 Results - Earnings Call Transcript

Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.

Why Avanos Medical Is Dropping Today

Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Q3 Earnings and Revenues Lag Estimates

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Avanos Medical Inc Stock (AVNS)